摘要目的:探讨Braden量表、NRS 2002对医用粘胶相关性皮肤损伤（MARSI）的预测价值。方法:采用便利抽样法，选取2018年1—12月在北京市某三级甲等医院治疗的612例ICU患者为研究对象，采用自行设计的一般资料收集表、Braden量表、NRS 2002收集资料。通过灵敏度、特异度及ROC曲线，评价Braden量表、NRS 2002及两者联合对ICU患者MARSI发生的预测作用。结果:612例ICU患者的MARSI发生率为11.3%（69/612）。发生MARSI患者与未发生MARSI患者的Braden量表、NRS 2002评分比较，差异有统计学意义（ P<0.01）。Braden量表、NRS 2002及两者联合预测ICU患者发生MARSI的ROC曲线下面积分别为0.564（95% CI 0.477~0.651）、0.670（95% CI 0.601~0.738）、0.724（95% CI 0.651~0.796），且两者联合预测MARSI发生的ROC曲线下面积高于单独应用Braden量表，差异有统计学意义（ P<0.01）。Braden量表联合NRS 2002预测MARSI的敏感度和特异度为0.739和0.663。 结论:ICU患者MARSI的发生率较高，Braden量表联合NRS 2002能有效预测ICU患者MARSI的发生。在临床护理工作中，护理人员可结合量表的评估结果进行恰当的皮肤护理，对患者进行有效预防与处理，保障皮肤安全。

abstractsObjective:To explore the predictive value of Braden Scale, Nutritional Risk Screening (NRS) 2002 for medical adhesive-related skin injury (MARSI) of patients in Intensive Care Unit (ICU) .Methods:Using the convenient sampling method, a total of 612 ICU patients who were treated in a ClassⅢ Grade A hospital in Beijing were selected as the research objects from January to December 2018. The self-designed general data collection form, Braden Scale and NRS 2002 were used to collect data. The sensitivity, specificity and ROC curve were used to evaluate the predictive effects of Braden scale, NRS 2002 and their combination on the occurrence of MARSI of patients in ICU.Results:The incidence of MARSI in 612 ICU patients was 11.3% (69/612) . There were statistically significant differences in Braden Scale and NRS 2002 scores between patients with MARSI and those without MARSI ( P<0.01) . The area under the ROC curve for Braden Scale, NRS 2002 and their combined prediction of MARSI of patients in ICU were respectively 0.564 (95% CI 0.477 - 0.651) , 0.670 (95% CI 0.601 - 0.738) and 0.724 (95% CI 0.651-0.796) and the area under the ROC curve for the joint prediction of MARSI of patients in ICU was higher than that of Braden Scale alone, and the difference was statistically significant ( P<0.01) . The sensitivity and specificity of Braden Scale combined with NRS 2002 for predicting MARSI of patients in ICU were 0.739 and 0.663. Conclusions:The incidence of MARSI is relatively high of patients in ICU, and Braden Scale combined with NRS 2002 can effectively predict the occurrence of MARSI. In clinical nursing work, nursing staff can combine the evaluation results of the scales to carry out appropriate skin care and effective prevention and treatment to ensure the skin safety of ICU patients.